← SynDRA
BEGACESTAT
SynDRA canonical compound SYN0018782 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | PSEN1 |
|---|
| Mechanism of action | gamma secretase inhibitor |
|---|
All known targets
- PSEN1
- APH1A
- APH1A; APH1B; NCSTN; PSENEN; PSEN1
- APH1B
- NCSTN
- PSEN2
- PSENEN
Mechanisms of action (all sources)
- APH1A INHIBITOR
- gamma-secretase inhibitor
- PSENEN INHIBITOR
- APH1B INHIBITOR
- PSEN1 INHIBITOR
- NCSTN INHIBITOR
- PSEN2 INHIBITOR
- Modulator
Drug classes
- Gamma Secretase Inhibitors and Modulators
Cross-references
Synonyms
- GSI-953
- PF-05212362
- PF-5212362
- WAY-201953
- WAY-210953
- GSI 953
- begacestatum
- RefChem:916805
- DTXCID50150201
- Begacestat [USAN]
- Begacestat [USAN:INN]
- UNII-3666C56BBU
- BEGACESTAT [INN]
- Begacestat (USAN/INN)
- GTPL6979
- orb1707577
- SCHEMBL3314371
- Begacestat, >=98% (HPLC)
- BDBM28922
- EX-A8618
- EBC-08721
- AKOS024458073
- HY-14175
- MS-26542
- DB-353671
- CS-0003249
- NS00071908
- D08869
- E98924
- T14525
- EN300-6745868
- BRD-K58319700-001-01-1
- Z2036684829
Look up BEGACESTAT in the interactive SynDRA portal →